September 12, 2020
Rose
A participant in the company’s late-stage coronavirus vaccine trial reportedly developed severe neurological symptoms. Now experts must assess whether the vaccine was responsible.
from Health https://ift.tt/2ReyIXD
September 12, 2020
Rose
Health, Health - The New York Times
No comments
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment